Abstract

Introduction: The concept of unified airway disease was recognized decades ago in asthma patients. Recent researches have indicated the presence and importance of rhinitis symptoms in COPD patients. Objective: The aim was to evaluate the impact of rhinitis symptoms on COPD severity and exacerbations. Material and methods: The prospective study included 49 patients, 24 (48,98%) female and 25 (51,02%) male, aged 66,49±7,461 years. The severity of COPD was determined by spirometric parameter FEV1%. The CAT questionnaire (COPD Assessment Test) was used to assess the COPD symptoms severity. The eosinophils were verified by blood count analysis, and the rhinitis symptoms were verified by SNOT-22 (Sino-nasal Outcome Test) questionnaire. Results: The rhinitis symptoms were found in 75,51% (37) of patients. A statistically significant differences in the total SNOT-22 score, the rhinological, extranasal/rhinological and auditory/facial domains of this questionnaire and blood eosinophilia in relation to the presence of rhinitis symptoms were observed (p<0,05). Correlation analysis confirmed a statistically significant relationship between the CAT and SNOT-22 scores (r=0,001; p<0,05), blood eosinophilia and the auditory/facial and psychological domains of SNOT-22 and its total score (r=0,05; r =0,024; r=0,011; p<0,05). Statistically significant correlation between the extranasal/rhinological domain and hospital exacerbations was also observed (r=0,038; p<0,05), as well as eosinophilia and the hospital exacerbations (r=0,019; p<0,05). The correlation between FEV1% and SNOT-22 score was not proven (r=0,183; p>0,05). Conclusion: The rhinitis symptoms significantly affects the expression of COPD symptoms and hospital exacerbations. Blood eosinophilia significantly affects the rhinitis symptoms and increases the risk of hospital exacerbations

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.